Search results
Results From The WOW.Com Content Network
Problematically, methicillin-resistant Staphylococcus aureus (MRSA) has become a major cause of hospital-acquired infections. MRSA has also been recognized with increasing frequency in community-acquired infections. [7] The symptoms of a staphylococcal infection include a collection of pus, such as a boil or furuncle, or abscess.
Although the disease is easily treatable, in severe cases boils may form inside the nostrils, which can cause cellulitis at the tip of the nose. The condition becomes serious because veins at that region of the face lead to the brain, and if bacteria spreads to the brain via these veins, the person may develop a life-threatening condition called cavernous sinus thrombosis, which is an ...
In situations where the incidence of MRSA infections is known to be high, the attending physician may choose to use a glycopeptide antibiotic until the identity of the infecting organism is known. After the infection is confirmed to be due to a methicillin-susceptible strain of S. aureus , treatment can be changed to flucloxacillin or even ...
Many of these infections are less serious, but the Centers for Disease Control and Prevention (CDC) estimate that there are 80,461 invasive MRSA infections and 11,285 deaths due to MRSA annually. [109] In 2003, the cost for a hospitalization due to MRSA infection was US$92,363; a hospital stay for MSSA was $52,791. [89]
Certain bacterial infections can be serious and in some cases, life-threatening, say experts.
MRSA ST398 is resistant to many antimicrobial agents; therefore, treatment options for this strain are limited. [8] However, hospitalization and aggressive treatment to treat the symptoms of MRSA ST398 can be employed. And until more information about antimicrobial susceptibilities are known, the ST398 strain should be treated as MRSA is. [9]
The infection is contagious and may spread to other areas of the body, or other people; those living in the same residence may develop carbuncles at the same time. [3] In the early 21st century, infection involving methicillin-resistant Staphylococcus aureus (MRSA) has become more common.
The diagnosis of vancomycin-resistant Staphylococcus aureus (VRSA) is performed by performing susceptibility testing on a single S. aureus isolate to vancomycin. This is accomplished by first assessing the isolate's minimum inhibitory concentration (MIC) using standard laboratory methods, including disc diffusion, gradient strip diffusion, and automated antimicrobial susceptibility testing ...